Molly Jenkins, Director of Public Affairs for the Pharmaceutical Research and Manufacturers of America (PhRMA), said that 340B entities can mark up medicines by over 1,000%, prescribe more expensive drugs, are less likely to use biosimilars, and... Read More »

Luke Gale, Revenue Cycle Editor for HealthLeaders Media, reported that the American Hospital Association claims drug companies are more likely than hospitals to violate 340B Drug Pricing Program rules and urged greater government oversight. Read More »

Every summer, many residents of Michigan celebrate Independence Day with fireworks. Read More »

As of June 30, 2025, the renewal period for Pharmacy Technician registrations and Pharmacy Facility licenses has concluded. Read More »

The Partnership for Safe Medicines (PSM) has issued a call to health care providers to verify the lot and serial numbers on Ozempic (semaglutide) 1 mg injection products. Read More »

Compounded topical finasteride products have been linked to significant risks, according to a warning from the Food and Drug Administration (FDA). Read More »

The International Pharmaceutical Federation (FIP) has released an updated version of its vaccination reference guide specifically for pharmacists. Read More »

The Institute for Safe Medication Practices (ISMP), an affiliate of ECRI, has raised concerns about potential medication errors involving two biologic drugs approved by the Food and Drug Administration (FDA). Read More »

The Food and Drug Administration has announced actions taken by the State of Texas against three compounding pharmacies for violations of the Texas State Board of Pharmacy Rules. Read More »

There were 98 drug shortages in 2024, as reported by the United States Pharmacopeia (USP). Read More »

On June 24, 2025, the North Carolina Department of Health and Human Services (NC DHHS) confirmed the state's first measles case of the year. Read More »

Brianna Allen, Senior Director of Public Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), said that hospitals are exploiting the 340B program to increase their profits, adversely affecting patients, taxpayers, and... Read More »

The Iowa Board of Pharmacy has announced the filing of charges against FarmaKeio, a mail-order compounding pharmacy, citing violations of the federal Food, Drug and Cosmetics Act. Read More »

The Michigan Department of Licensing and Regulatory Affairs (LARA) has introduced the MiBusiness Registry Portal, a new online platform aimed at enhancing business filing services in the state. Read More »

The Women, Infants, and Children (WIC) program has announced new income guidelines for 2025. Read More »

The National Community Pharmacists Association (NCPA) has expressed disappointment following the U.S. Supreme Court's decision not to review a case concerning pharmacy benefit manager (PBM) reform in Oklahoma. Read More »

The God Particle, a trader on the social media platform X, said that legal precedent and federal law do not permit companies to sue compounding pharmacies over practices allowed under Section 503A of the Food, Drug, and Cosmetic Act. Read More »

The Mississippi Board of Pharmacy is seeking to fill the position of Legal Counsel in Jackson, MS. Read More »

The New Mexico Securities Division has joined a multistate settlement with several financial firms accused of overcharging customers. Read More »

Michigan businesses are being warned about a fraudulent scheme involving mail solicitations from an entity named "New Business Filing LLC." Read More »